Aevi Genomic Medicine, Inc. 4
4 · Aevi Genomic Medicine, Inc. · Filed Feb 17, 2017
Insider Transaction Report
Form 4
Piper Brian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase)
2017-02-17+190,000→ 190,000 totalExercise: $4.91Exp: 2027-02-17→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]The option award vests and becomes exercisable in three equal installments (rounded up to the nearest whole share of common stock) on February 17, 2018, February 17, 2019 and February 17, 2020, subject to the reporting person's continued service with the issuer.